Form D — UBIVAC, INC.
0001713945-26-000003 · filed Aug 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- —
- Reported amount sold
- $80,000
- Minimum investment
- $10,000
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- UBIVAC, INC.
- CIK
- 1713945
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 18183 S.W. BOONES FERRY ROAD
PORTLAND, OR 97224 - Phone
- 503-292-4066
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Bernard Fox, Ph.D. · Executive OfficerPortland, OR Find on LinkedIn ↗
-
Hong-Ming Hu, Ph.D. · Executive OfficerPortland, OR Find on LinkedIn ↗
-
Bernard A. Fox, III · Executive OfficerPortland, OR Find on LinkedIn ↗
-
Sung Poblete, R.N., Ph.D. · DirectorPortland, OR Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗